Wang Zhimin
rofessor/PI
Shanghai Institute for Biomedical and Pharmaceutical Technologies
Back to List
Charting the Future: A Strategic Roadmap for Shanghai's Bioprinting Industry—Insights and Prospects from an Industry Whitepaper
【Abstract】1.Overview of Bioprinting Technology
2.Strategic Focus Areas Informed by Patent Landscape Analysis
3.Industry Insights and Future Directions from a Whitepaper Perspective
4.Convergence of Bioprinting and Organoid Technology
【Bio】
Name: Wang Zhimin Position: Ph.D./Professor, Head of the Interdisciplinary Research Group (IRG) Education: Ph.D. from Fudan University Research Profile :Dr. Wang Zhimin has focused on stem cell research (regenerative medicine, organoids, bioprinting) .Authored more than 60 papers in international journals including Molecular Cancer, Materials Today Bio, and International Journal of Bioprinting. Co-editor of Stem Cells: The Light of Regenerative Medicine (part of the "Light of Science and Innovation" series), recognized as one of the 100 Outstanding Books by the National Press and Publication Administration and awarded Shanghai Excellent Science Popularization Work (2018).Additionally, Holds 8 authorized national invention patents.Completed technology transfer for one patent (as first inventor) through the Shanghai Technology Exchange.He has led more than 10 research projects, with total funding exceeding 12 million RMB. Honors and Awards: 2009: Shanghai Rising-Star Program for Young Scientists,2017: Shanghai Talent Development Fund,2018: Shanghai May 4th Youth Medal. Academic Roles:Editorial Board Member: Biomedical and Environmental Sciences, Chinese Journal of Preventive Medicine.Vice Chairperson: Hereditary Gastrointestinal Tumor Professional Committee, Shanghai Anticancer Association.Council Member: Shanghai Society of Genetics.
TCT Asia
